Cover Image
市場調查報告書

CYATHUS EXQUIRERE PharmaforschungsGmbH - 產品平台分析

CYATHUS EXQUIRERE PharmaforschungsGmbH - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 311247
出版日期 內容資訊 英文 17 Pages
訂單完成後即時交付
價格
Back to Top
CYATHUS EXQUIRERE PharmaforschungsGmbH - 產品平台分析 CYATHUS EXQUIRERE PharmaforschungsGmbH - Product Pipeline Review - 2015
出版日期: 2015年05月27日 內容資訊: 英文 17 Pages
簡介

CYATHUS EXQUIRERE PharmaforschungsGmbH是研發醫藥品製劑及藥物遞輸技術的製藥公司。此外更一面進行技術導出引入、上市後醫藥品安全監控、醫藥品共同開發等。更一面與產學研究機關積極合作,以配合產品的開發。

本報告提供CYATHUS EXQUIRERE PharmaforschungsGmbH的治療藥開發平台現狀及各開發階段比較分析,為您彙整藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

CYATHUS EXQUIRERE PharmaforschungsGmbH的基本資料

CYATHUS EXQUIRERE PharmaforschungsGmbH概要

  • 主要資訊
  • 企業資料

CYATHUS EXQUIRERE PharmaforschungsGmbH:R&D概要

  • 主要的治療範圍

CYATHUS EXQUIRERE PharmaforschungsGmbH:開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品

CYATHUS EXQUIRERE PharmaforschungsGmbH:開發中產品概況

  • 初期階段產品開發中產品
    • 前臨床階段的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式

CYATHUS EXQUIRERE PharmaforschungsGmbH:藥物簡介

  • Cyathus-1102-B
  • Cyathus-1103-B
  • Cyathus-1105-B
  • Cyathus-1104-B

CYATHUS EXQUIRERE PharmaforschungsGmbH:總公司和子公司的所在地

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07134CDB

Summary

Global Markets Direct's, 'CYATHUS EXQUIRERE PharmaforschungsGmbH - Product Pipeline Review - 2015', provides an overview of the CYATHUS EXQUIRERE PharmaforschungsGmbH's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of CYATHUS EXQUIRERE PharmaforschungsGmbH's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of CYATHUS EXQUIRERE PharmaforschungsGmbH including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of CYATHUS EXQUIRERE PharmaforschungsGmbH's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the CYATHUS EXQUIRERE PharmaforschungsGmbH's pipeline products

Reasons to buy

  • Evaluate CYATHUS EXQUIRERE PharmaforschungsGmbH's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of CYATHUS EXQUIRERE PharmaforschungsGmbH in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the CYATHUS EXQUIRERE PharmaforschungsGmbH's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of CYATHUS EXQUIRERE PharmaforschungsGmbH and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of CYATHUS EXQUIRERE PharmaforschungsGmbH
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of CYATHUS EXQUIRERE PharmaforschungsGmbH and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • CYATHUS EXQUIRERE PharmaforschungsGmbH Snapshot
    • CYATHUS EXQUIRERE PharmaforschungsGmbH Overview
    • Key Information
    • Key Facts
  • CYATHUS EXQUIRERE PharmaforschungsGmbH - Research and Development Overview
    • Key Therapeutic Areas
  • CYATHUS EXQUIRERE PharmaforschungsGmbH - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • CYATHUS EXQUIRERE PharmaforschungsGmbH - Pipeline Products Glance
    • CYATHUS EXQUIRERE PharmaforschungsGmbH - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • CYATHUS EXQUIRERE Pharmaforschungs GmbH - Drug Profiles
    • Cyathus-1102-B
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Cyathus-1103-B
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Cyathus-1105-B
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Cyathus-1104-B
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • CYATHUS EXQUIRERE PharmaforschungsGmbH - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • CYATHUS EXQUIRERE PharmaforschungsGmbH, Key Information
  • CYATHUS EXQUIRERE PharmaforschungsGmbH, Key Facts
  • CYATHUS EXQUIRERE PharmaforschungsGmbH - Pipeline by Indication, 2015
  • CYATHUS EXQUIRERE PharmaforschungsGmbH - Pipeline by Stage of Development, 2015
  • CYATHUS EXQUIRERE PharmaforschungsGmbH - Monotherapy Products in Pipeline, 2015
  • CYATHUS EXQUIRERE PharmaforschungsGmbH - Preclinical, 2015
  • CYATHUS EXQUIRERE PharmaforschungsGmbH - Discovery, 2015
  • CYATHUS EXQUIRERE PharmaforschungsGmbH, Subsidiaries

List of Figures

  • CYATHUS EXQUIRERE PharmaforschungsGmbH - Pipeline by Top 10 Indication, 2015
  • CYATHUS EXQUIRERE PharmaforschungsGmbH - Pipeline by Stage of Development, 2015
  • CYATHUS EXQUIRERE PharmaforschungsGmbH - Monotherapy Products in Pipeline, 2015
Back to Top